Dai Ichi Life Insurance Company, LTD Bristol Myers Squibb CO Transaction History

Dai Ichi Life Insurance Company, LTD

  • $4.06 Billion
  • Q2 2024

A detailed history of Dai Ichi Life Insurance Company, LTD transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Dai Ichi Life Insurance Company, LTD holds 16,197 shares of BMY stock, worth $861,518. This represents 0.02% of its overall portfolio holdings.

Number of Shares
16,197
Previous 31,252 48.17%
Holding current value
$861,518
Previous $1.69 Million 60.33%
% of portfolio
0.02%
Previous 0.04%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024
SELL
$40.25 - $52.99 $605,963 - $797,764
-15,055 Reduced 48.17%
16,197 $672,000
Q1 2024

May 09, 2024
SELL
$47.98 - $54.4 $351,741 - $398,806
-7,331 Reduced 19.0%
31,252 $1.69 Million
Q4 2023

Feb 09, 2024
SELL
$48.48 - $57.85 $16.8 Million - $20 Million
-345,538 Reduced 89.96%
38,583 $1.98 Million
Q3 2023

Nov 02, 2023
SELL
$57.89 - $64.73 $3.71 Million - $4.14 Million
-64,029 Reduced 14.29%
384,121 $22.3 Million
Q2 2023

Aug 11, 2023
SELL
$63.71 - $70.74 $1.69 Million - $1.87 Million
-26,477 Reduced 5.58%
448,150 $28.7 Million
Q1 2023

May 15, 2023
BUY
$65.71 - $74.53 $1.54 Million - $1.75 Million
23,472 Added 5.2%
474,627 $32.9 Million
Q4 2022

Feb 14, 2023
BUY
$68.48 - $81.09 $7.69 Million - $9.11 Million
112,346 Added 33.16%
451,155 $32.5 Million
Q3 2022

Nov 14, 2022
BUY
$0.13 - $76.84 $697 - $412,169
5,364 Added 1.61%
338,809 $24.1 Million
Q2 2022

Aug 12, 2022
BUY
$72.62 - $79.98 $5.19 Million - $5.72 Million
71,464 Added 27.28%
333,445 $25.7 Million
Q1 2022

May 13, 2022
BUY
$61.48 - $73.72 $3.17 Million - $3.8 Million
51,603 Added 24.53%
261,981 $19.1 Million
Q4 2021

Feb 11, 2022
SELL
$53.63 - $62.52 $1.48 Million - $1.72 Million
-27,551 Reduced 11.58%
210,378 $13.1 Million
Q3 2021

Nov 04, 2021
SELL
$59.17 - $69.31 $1.6 Million - $1.87 Million
-27,011 Reduced 10.2%
237,929 $14.1 Million
Q2 2021

Aug 13, 2021
BUY
$61.91 - $67.42 $1.37 Million - $1.49 Million
22,160 Added 9.13%
264,940 $17.7 Million
Q1 2021

May 13, 2021
SELL
$59.34 - $66.74 $568,714 - $639,636
-9,584 Reduced 3.8%
242,780 $15.3 Million
Q4 2020

Feb 11, 2021
BUY
$57.74 - $65.43 $540,677 - $612,686
9,364 Added 3.85%
252,364 $15.7 Million
Q3 2020

Nov 12, 2020
BUY
$57.43 - $63.64 $1.4 Million - $1.55 Million
24,328 Added 11.13%
243,000 $14.7 Million
Q2 2020

Aug 12, 2020
SELL
$54.82 - $64.09 $158,155 - $184,899
-2,885 Reduced 1.3%
218,672 $12.9 Million
Q1 2020

May 08, 2020
SELL
$46.4 - $67.43 $2.31 Million - $3.36 Million
-49,852 Reduced 18.37%
221,557 $12.4 Million
Q4 2019

Feb 13, 2020
BUY
$49.21 - $64.19 $4.61 Million - $6.02 Million
93,744 Added 52.76%
271,409 $17.4 Million
Q3 2019

Nov 13, 2019
BUY
$42.77 - $50.71 $90,244 - $106,998
2,110 Added 1.2%
177,665 $9.01 Million
Q2 2019

Aug 14, 2019
SELL
$44.62 - $49.34 $11.3 Million - $12.5 Million
-252,549 Reduced 58.99%
175,555 $7.96 Million
Q1 2019

May 14, 2019
BUY
$45.12 - $53.8 $10 Million - $11.9 Million
221,679 Added 107.39%
428,104 $20.4 Million
Q4 2018

Feb 14, 2019
SELL
$48.76 - $63.23 $527,583 - $684,148
-10,820 Reduced 4.98%
206,425 $10.7 Million
Q3 2018

Nov 13, 2018
SELL
$55.19 - $62.25 $148,295 - $167,265
-2,687 Reduced 1.22%
217,245 $13.5 Million
Q2 2018

Aug 10, 2018
SELL
$50.53 - $62.98 $1.02 Million - $1.28 Million
-20,247 Reduced 8.43%
219,932 $12.2 Million
Q1 2018

May 15, 2018
SELL
$59.92 - $68.98 $496,077 - $571,085
-8,279 Reduced 3.33%
240,179 $15.2 Million
Q4 2017

Feb 13, 2018
SELL
$59.94 - $65.35 $221,118 - $241,076
-3,689 Reduced 1.46%
248,458 $15.2 Million
Q3 2017

Nov 09, 2017
BUY
$55.23 - $63.74 $13.9 Million - $16.1 Million
252,147
252,147 $16.1 Million

Others Institutions Holding BMY

# of Institutions
2,428
Shares Held
1.5B
Call Options Held
29.7M
Put Options Held
32.2M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Dai Ichi Life Insurance Company, LTD Portfolio

Follow Dai Ichi Life Insurance Company, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dai Ichi Life Insurance Company, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dai Ichi Life Insurance Company, LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email